Psoriatic Arthritis
📧 Sign up to get email alerts when something new happens for Psoriatic Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
A Phase 3 clinical trial is evaluating the effect of Bimekizumab on gene expression biomarkers in adults with moderate to severe plaque psor…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults [Phase 1]
A Phase 1 clinical trial is evaluating the safety and pharmacokinetics of bimekizumab given in different administration methods in adults wi…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Subjects With Active Psoriatic Arthritis [Phase 2]
A Phase II clinical trial update indicating that D-2570 is being studied for efficacy and safety in active psoriatic arthritis and is curren…
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Study of SPY072 in Rheumatic Disease [Phase 2]
This clinical trials update outlines a Phase 2 study of SPY072 for rheumatoid arthritis and psoriatic arthritis, with ongoing recruitment an…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO [Phase 1]
Phase 1 trial evaluating nivolumab in patients with autoimmune disorders and advanced cancers; the study is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Oxidative Stress in Autoimmune Rheumatic Diseases
A University of Thessaly–sponsored clinical trial is recruiting to study oxidative stress in autoimmune rheumatic diseases, including rheuma…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases [Phase 4]
Phase 4 clinical trial assessing safety and immunogenicity of the live attenuated tetravalent Butantan-Dengue vaccine in autoimmune rheumati…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic Arthritis [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of Icotrokinra in biologic-experienced participants with active psoriatic arthriti…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis [Phase 3]
Phase 3 trial evaluating the efficacy and safety of JNJ-77242113 (Icotrokinra) in biologic-naïve participants with active psoriatic arthriti…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical Practice
This clinical trial update describes a study evaluating guselkumab and an interleukin-17 (IL-17) inhibitor in psoriatic arthritis in routine…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants [Phase 3]
A long-term extension study of guselkumab in pediatric participants with Crohn's disease, ulcerative colitis, psoriatic arthritis, and juven…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis [Phase 2]
This is a Phase 2 clinical trial to evaluate the efficacy and safety of JNJ-88545223 in participants with active psoriatic arthritis. The st…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA) [Phase 4]
Phase 4 clinical trial update indicating guselkumab is being studied in Indian participants for psoriatic arthritis and is currently recruit…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic Arthritis [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy and safety of bimekizumab in adults with active psoriatic arthritis; the study is curren…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015) [Phase 2]
Phase 2 clinical trial MK-7240-015 evaluating Tulisokibart in adults with psoriatic arthritis is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease [Phase 4]
A Phase 4 study evaluating subcutaneous guselkumab in bio-naive participants with active psoriatic arthritis axial disease; the trial status…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Pain in Inflammatory Joint Diseases
The clinical trial update reports that a study on pain in inflammatory joint diseases is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting
A real-world study of guselkumab in adults with psoriatic arthritis is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Psoriasis Comorbidities at Hospital Calderón Guardia
A clinical trial in Costa Rica investigates psoriasis and psoriatic arthritis comorbidities, with recruitment not yet started.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines [Phase 3]
A Phase 3 clinical trial evaluating Zasocitinib in adults with psoriatic arthritis who have not previously used biologic medicines; currentl…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines [Phase 3]
An ongoing Phase 3 study evaluating Zasocitinib in adults with psoriatic arthritis, including participants who have and have not previously …
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab) [Phase 1]
A Phase 1 study is evaluating the concentration of Bimzelx (bimekizumab) in mature breast milk in mothers receiving treatment, and is curren…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: TNFAIP3 Gene Expression in Ankylosing Spondylitis and Psoriatic Arthritis Patients and Its Relation to Disease Activity [NA]
A clinical trial update examining TNFAIP3 gene expression in patients with ankylosing spondylitis and psoriatic arthritis and its relationsh…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps
A safety study of Remsima SC for rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, and psoriasis remains active but not rec…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug [Phase 3]
Phase 3 study evaluating Sonelokimab for Psoriatic arthritis in biologic DMARD-naive patients; the study is currently ACTIVE_NOT_RECRUITING.